2013-10-31 22:09:02 -
CARY, NC -- (Marketwired) -- 10/31/13 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, November 7, 2013, to discuss its financial results for the third quarter of 2013 ended September 30, 2013. Financial results are expected to be released before the open of the U.S. financial markets on Thursday, November 7, 2013.
To participate in the live conference call, please dial 888-505-4368 (U.S. callers) or 719-325-2420 (international callers), and provide passcode1373925. A live webcast of the call will also be available through the Investor Relations section : ctt.marketwire.com/?release=1064021&id=3605257&type=1&am ..
of the Company's website. Please allow extra time prior to the webcast to register, download and install any necessary audio software.
The conference call and the webcast will be archived for 30 days. The telephone replay of the call will be available approximately two hours after completion of the call by dialing 888-203-1112 (U.S. callers) or 719-457-0820 (international callers), and providing passcode 1373925.
About Cornerstone Therapeutics
Cornerstone Therapeutics Inc. (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Key elements of the Company's strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek out opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within the Company's focus areas; and generate revenues by marketing approved generic products through the Company's wholly-owned subsidiary, Aristos Pharmaceuticals, Inc. For more information, visit www.crtx.com : ctt.marketwire.com/?release=1064021&id=3605260&type=1&am ..
Investor Relations Contact:
Vice President, Strategy and Business Development
Media Relations Contact:
docid: 131064021.nitf -->